Overview

The Effect in Renal Function on Patients With Type 1 Cardiorenal Syndrome Treated With Two Strategies of Furosemide.

Status:
Completed
Trial end date:
2020-04-01
Target enrollment:
Participant gender:
Summary
In double-blind clinical trial, determine renal recovery with two different furosemide strategies in patients with type 1 cardiorenal syndrome.
Phase:
Phase 2
Details
Lead Sponsor:
Hospital Civil de Guadalajara
Treatments:
Chlorthalidone
Furosemide
Spironolactone